Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
734 articles
📰
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
Key highlights for the first full year of operation under the new management team include:
📰
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
Key highlights for the first full year of operation under the new management team include:
A year-over-year reduction in operating expenses with...
📰
American Shared Hospital Services Announces Fourth Quarter and Full Year Financial Results Conference Call
SAN FRANCISCO, March 24, 2026 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic...
📰
CAMP4 Appoints Michael MacLean to its Board of Directors
CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the Company") (NASDAQ:CAMP), a clinical-stage...
📰
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
SAN DIEGO, March 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro...
📰
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
FDA encourages the Company to submit comprehensive data from sunRIZE and the ongoing open-label extension to inform next steps for the program FDA...
📰
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of...
IDEMIA Secure Transactions Powers Spain's Nationwide Mandatory Rollout of Emergency Beacons with its Secure Connectivity
COURBEVOIE, France, March 24, 2026 /PRNewswire/ -- IDEMIA Secure Transactions (IST), a global leader in secure connectivity solutions, is...
IDEMIA Secure Transactions Powers Spain's Nationwide Mandatory Rollout of Emergency Beacons with its Secure Connectivity
COURBEVOIE, France, March 24, 2026 /PRNewswire/ -- IDEMIA Secure Transactions (IST), a global leader in secure connectivity solutions, is...
JRE-Jeunes Restaurateurs y UNITED WATERWAYS se asocian para elevar las experiencias culinarias en el río
EINDHOVEN, Países Bajos, 24 de marzo de 2026 /PRNewswire/ -- JRE-Jeunes Restaurateurs y UNITED WATERWAYS anunciaron una alianza estratégica para...
JRE-Jeunes Restaurateurs et UNITED WATERWAYS s'associent pour améliorer les expériences culinaires sur le fleuve
EINDHOVEN, Pays-Bas, 24 mars 2026 /PRNewswire/ -- JRE-Jeunes Restaurateurs et UNITED WATERWAYS ont annoncé un partenariat stratégique en vue d'élever...
JRE-Jeunes Restaurateurs and UNITED WATERWAYS Partner to Elevate Culinary River Experiences
EINDHOVEN, Netherlands, March 24, 2026 /PRNewswire/ -- JRE-Jeunes Restaurateurs and UNITED WATERWAYS announced a strategic partnership to raise...
JRE-Jeunes Restaurateurs and UNITED WATERWAYS Partner to Elevate Culinary River Experiences
EINDHOVEN, Netherlands, March 24, 2026 /PRNewswire/ -- JRE-Jeunes Restaurateurs and UNITED WATERWAYS announced a strategic partnership to raise...
JRE-Jeunes Restaurateurs und UNITED WATERWAYS kooperieren, um kulinarische Erlebnisse bei der Passagier-Flussschifffahrt zu verbessern
EINDHOVEN, Niederlande, 24. März 2026 /PRNewswire/ -- JRE-Jeunes Restaurateurs und UNITED WATERWAYS kündigten eine strategische Partnerschaft an, um...
📰
DualityBio (9606.HK) Announces 2025 Annual Results
HONG KONG, March 24, 2026 /PRNewswire/ -- Duality Biotherapeutics, Inc. (Hong Kong Stock Exchange Code: 09606.HK, hereinafter referred to as...
📰
Press release: Availability of the Q1 2026 aide-mémoire
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
Elon Musk Should Borrow A Page From Steve Jobs And Create A Brand Identity For His EV Giant, Says Gary Black: 'Who Does Tesla Stand For…'
On Monday, investor Gary Black said that Tesla Inc. (NASDAQ:TSLA) risks falling short on brand clarity despite strong products. He urged Elon Musk to...
Google And Meta's Fate Hangs In The Balance As Jury Signals Deadlock In Social Media Addiction Trial
On Monday, jurors in the social media addiction trial told the court that they are struggling to agree on a verdict involving one of the...
📰
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action – CORT
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
Tim Cook Warns Against Endless Scrolling — Ryanair Touts No Wi-Fi As A Perk
On Monday, Europe's largest low-cost airline, Ryanair Holdings PLC (NASDAQ:RYAAY), responded to Tim Cook’s statement that users should...
📰
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Bionano Genomics (BNGO) Earnings Transcript
Image source: The Motley Fool.Monday, March 23, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰
Outlook Therapeutics Announces Proposed Public Offering
ISELIN, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the...
📰
Outlook Therapeutics Announces Proposed Public Offering
ISELIN, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the...
BLRX: Full Year 2025 Results
By John Vandermosten, CFA
NASDAQ: BLRX
READ THE FULL BLRX RESEARCH REPORT
BioLineRx Ltd. (NASDAQ: BLRX) reported 2025 financial and operational...
📰
Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results
Daix (France), New York (United States), March 23, 2026 – Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical...
Perimeter Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 31st; Provides Corporate Update
TORONTO and DALLAS, March 23, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a...
📰
Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results
Daix (France), New York (United States), March 23, 2026 – Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical...
Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) will release earnings results for its fourth quarter, before the opening bell on Tuesday, March...
📰
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme...
📰
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease
📰
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
Phase 1a interim data for ongoing trial of CTIM-76 (CLDN6 x CD3) expected in June 2026
Phase 1a interim data for ongoing trial of CT-95 (MSLN x CD3)...
📰
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
Phase 1a interim data for ongoing trial of CTIM-76 (CLDN6 x CD3) expected in June 2026
📰
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
Conference call today, March 23, 2026, at 4:30 PM ET Conference call today, March 23, 2026, at 4:30 PM ET